The other side of the coin: Harm due to the non-use of health-related data

International Journal of Medical Informatics

Volumn 97, Issue , 2017, Pages 43-51

  Jones, Kerina H ^a   Laurie, Graeme ^b   Stevens, Leslie ^b   Dobbs, Christine ^a   Ford, David V ^a   Lea, Nathan ^c  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Harm; Health data; Non use; Omission

Indexed keywords

CASE STUDY APPROACH; CLINICAL CARE; HARM; HEALTH DATA; NON-USE; OMISSION; REAL PROBLEMS; RESEARCH DATA;

HEALTH;

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; FINANCIAL MANAGEMENT; INFORMATION PROCESSING; MEDICAL INFORMATICS; MEDICAL INFORMATION; PRIORITY JOURNAL; HARM REDUCTION; INFORMATION SYSTEM; MEDICAL INFORMATION SYSTEM; RESEARCH;

HARM REDUCTION; HEALTH INFORMATION SYSTEMS; INFORMATION MANAGEMENT; RESEARCH;

EID: 84988963459     PISSN: 13865056     EISSN: 18728243     Source Type: Journal    
DOI: 10.1016/j.ijmedinf.2016.09.010     Document Type: Article

References (80)

1. [1] Laurie, G., Jones, K.H., Stevens, L., Dobbs, C., A Review of Evidence Relating to Harm Resulting from Uses of Health and Biomedical Data., 2015, Nuffield Council on Bioethics http://nuffieldbioethics.org/wp-content/uploads/FINAL-Report-on-Harms-Arising-from-Use-of-Health-and-Biomedical-Data-30-JUNE-2014.pdf.
2. [2] National Audit Office, 1995. http://webarchive.nationalarchives.gov.uk/20111203034031/http://www.audit-commission.gov.uk/SiteCollectionDocuments/AuditCommissionReports/NationalStudies/SettingtheRecordsStraight.pdf.
3. [3] Yoong, A., Hudson, C., Chard, T., Medical audit − the problem of missing notes. Health Trends, 25(13), 1993.
4. [4] Ford, D.V., Jones, K.H., Middleton, R.M., Lockhart-Jones, H., Maramba, I.D.C., Noble, J.G., Osborne, L.A., Lyons, R.A., The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS. BMC Med. Inform. Decis. Mak., 12(1), 2012, 73, 10.1186/1472-6947-12-73.
5. [5] Middleton, R.M., Tuite-Dalton, K., Ford, D.V., Noble, J.G., Osborne, L.A., Maramba, C., Lockhart-Jones, H., Jones, K.H., Clinical System Usage in NHS Specialist Neurology Sites (poster Presentation) RIMS Conference, Brighton, June, 2014, 2014.
6. [6] The Information Governance Review, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/192572/2900774_InfoGovernance_accv2.pdf.
7. [7] Academy of Medical Sciences, 2012. https://www.acmedsci.ac.uk/viewFile/51dd839626e27.pdf.
8. [8] Cresswell, K., Sheikh, A., Organizational issues in the implementation and adoption of health information technology innovations: an interpretative review. IJMI 82:5 (2013), 73–86.
9. [9] Lluch, M., Healthcare professionals’ organisational barriers to health information technologies-a literature review. IJMI 80:12 (2011), 849–862.
10. [10] Viitanin, J., Hyppönen, H., Lääveri, T., Vänskä, J., Reponen, J., Winblad, I., National questionnaire study on clinical ICT systems proofs: physicians suffer from poor usability. IJMI 80:10 (2011), 708–725.
11. [11] Digital Health Intelligencei, EPR implementation led to ‘catastrophic loss of confidence. http://www.digitalhealth.net/clinical_software/47217/epr-implementation-led-to-'catastrophic-loss-of-confidence.
12. [12] Iacobucci, G., Sharing care data could save lives of vulnerable children, hospital leader says. BMJ, 348, 2014, g1953.
13. [13] Field, L., Suhr, S., Ison, J., Los, W., Wittenberg, P., Broeder, D., Hardisty, A., Repo, S., Jenkinson, A., Realising the full potential of research data: common challenges in data management, sharing and integration across scientific disciplines. 2013 https://zenodo.org/record/7636/files/Common_Challenges-v3.pdf.
14. [14] Health and Social Care Information Centre. http://systems.hscic.gov.uk/data/uktc/readcodes.
15. [15] World Health Organisation. http://www.who.int/classifications/icd/en/.
16. [16] Health and Social Care Information Centre. http://systems.hscic.gov.uk/data/clinicalcoding/codingstandards/opcs4.
17. [17] Health and Social Care Information Centre. http://systems.hscic.gov.uk/data/uktc/snomed.
18. [18] Berner, E.S., Graber, M.L., Overconfidence as a cause of diagnostic error in medicine. Am. J. Med. 121:suppl. 5 (2008), S2–S23.
19. [19] Leape, L., Berwick, D., Bates, D., Counting deaths from medical errors [letter reply]. JAMA, 288(19), 2002, 2405.
20. [20] Graber, M.L., Wachter, R.M., Cassel, C.K., Bringing diagnosis into the quality and safety equations. JAMA 308:12 (2012), 1211–1212.
21. [21] Rusanov, A., Weiskopf, N.G., Wang, S., Weng, C., Hidden in plain sight: bias towards sick patients when sampling patients with sufficient electronic health record data for research. BMC Med. Inform. Decis. Mak., 14, 2014, 51, 10.1186/1472-6947-14-51.
22. [22] Expert Advisory Group on Data Access, Establishing Incentives and Changing Cultures to Support Data Access. 2014 http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_peda/documents/web_document/wtp056495.pdf.
23. [23] Brutscher, P.-B., Wooding, S., Grant, J., Health Research Evaluation Frameworks: An International Comparison., 2008, RAND, Europe http://www.rand.org/content/dam/rand/pubs/technical_reports/2008/RAND_TR629.pdf.
24. [24] Shaw, D., Unethical framework. Times Higher Education. 2012 https://www.timeshighereducation.com/news/unethical-framework/418830.article.
25. [25] Journal of Negative Results in Biomedicine. http://www.jnrbm.com/about.
26. [26] Forbes, The Cost Of Creating A New Drug Now $5 Billion, Pushing Big Pharma To Change. 2013 http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/.
27. [27] Goldacre, B., Bad Pharma: How Medicine Is Broken and How We can Fix It. 2013, Fourth Estate publishers ISBN-13: 978-0007498086.
28. [28] Attarwala, H., TGN:1412 From discovery to disaster. J. Young Pharm. 2:3 (2010), 332–336 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964774/.
29. [29] Decuilier, E., Chan, A.-W., Chapuis, F., Inadequate dissemination of phase 1 trials: a retrospective cohort study. PLoS Med., 6(February (2)), 2009, e10000034 17.
30. [30] Butler, D., Callaway, E., Scientists in the dark after French clinical trial proves fatal. Nature 529 (2016), 263–264, 10.1038/nature.2016.19189.
31. [31] Cowley, A.J., Skene, A., Stainer, K., Hampton, J.R., The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. Int. J. Cardiol. 40:2 (1993), 161–166.
32. [32] Cohen, D., Dabigatran: how the drug company withheld important analyses. BMJ, 349, 2014, g4670, 10.1136/bmj.g4670.
33. [33] BoehringerIngleheim, Investigational Antidote for Pradaxa (Dabigatran Etexilate Mesylate) Receives FDA Breakthrough Therapy Designation. Press release. 2014 http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2014/06-26-14-boehringer-ingelheim-investigational-antidote-pradaxa-dabigatran-etexilate-mesylate-fda-breakthrough-therapy-designation.html.
34. [34] Goldacre, B., Are clinical trial data shared sufficiently today?. BMJ, 347, 2013, f1880, 10.1136/bmj.f1880.
35. [35] Cohen, D., Rivoraxaban: can we trust the evidence?. BMJ, 352, 2016, i575, 10.1136/bmj.i575.
36. [36] Godlee, F., Data transparency is the only way. BMJ, 352, 2016, i1261, 10.1136/bmj.i1261.
37. [37] Anderson, M.L., Chiswell, K., Peterson, E.D., Tasneem, A., Topping, J., Califf, R.M., Compliance with results reporting at ClinicalTrials.gov. NEJM 372:March (2015), 1031–1039, 10.1056/NEJMsa1409364 12.
38. [38] STAT. https://www.statnews.com/2015/12/13/clinical-trials-investigation/.
39. [39] All Trials. http://www.alltrials.net/.
40. [40] Elwyn, G., Seagrove, A., Thorne, K., Chung, W.Y., Ethics and research governance in a multicentre study: add 150 days to your study protocol. BMJ, 330, 2005, 847, 10.1136/bmj.330.7495.847.
41. [41] Dumville, J.C., Watson, J., Raynor, P., Torgeson, D.J., Research governance: a barrier to ethical research?. QJM, 2004, 113–114, 10.1093/qjmed/hch026.
42. [42] The Farr Institute of Health Informatics Research. http://www.farrinstitute.org/.
43. [43] The Global Open Data Initiative. http://globalopendatainitiative.org/.
44. [44] Open Data Roadmap for the UK – 2015. http://theodi.org/roadmap-uk-2015.
45. [45] MRC. Data Sharing Policy. http://www.mrc.ac.uk/research/research-policy-ethics/data-sharing/policy/.
46. [46] Global Alliance for Genomics and Health. https://genomicsandhealth.org/.
47. [47] Ipsos MORI Social Research Institute, 2014. Dialogue on data. https://www.ipsos-mori.com/DownloadPublication/1652_sri-dialogue-on-data-2014.pdf.
48. [48] HM Government, Data Protection Act 1998. http://www.legislation.gov.uk/ukpga/1998/29/contents.
49. [49] European Medicines Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000570.jsp.
50. [50] Perera, G., Holbrook, A., Thabane, L., Foster, G., Willison, D.J., Views on health information sharing and privacy from primary care practices using electronic medical records. IJMI 80:2 (2011), 94–101.
51. [51] Carter, P., Laurie, G.T., Dixon-Woods, M., The social licence for research: why care.data ran into trouble. J. Med. Ethics, 2014, 10.1136/medethics-2014-102374.
52. [52] Lea, N., Nicolls, J., Are patient relationships the driver for information governance?. BJGP, 2016, 10.3399/bjgp16X685753 July 2016.
53. [53] Wellcome Trust, Wellcome Trust Monitor Summary Report Wave 3: Tracking Public Views on Science and Biomedical Research., 2016 https://wellcome.ac.uk/sites/default/files/monitor-wave3-summary-wellcome-apr16.pdf.
54. [54] Health Research Authority. http://www.hra.nhs.uk/.
55. [55] Laurie, G.T., Postan, E., Rhetoric or reality: what is the legal status of the consent form in health-related research?. Med. Law Rev., 2012, 10.1093/medlaw/fws031.
56. [56] Stanley, F., 2010. Privacy or public good? Why not obtaining consent may be best practice. Volume 7. Issue 2. June 2010. DOI: 10.1111/j.1740-9713.2010.00423.x.
57. [57] Dyer, C., Stringent constraints on use of patients' data are harming research. BMJ, 2007, 2007, 335 1114.3.
58. [58] NHS Act, 2006. http://www.legislation.gov.uk/ukpga/2006/41.
59. [59] Health Research Authority, Confidentiality Advisory Group http://www.hra.nhs.uk/about-the-hra/our-committees/section-251/what-is-section-251/.
60. [60] Building Blocks 2-6: Evaluating the long-term effectiveness, and the cost and consequences of the Family Nurse Partnership parenting support programme in reducing maltreatment in young children http://medicine.cardiff.ac.uk/clinical-study/building-blocks-2/.
61. [61] Jones, K.H., Ford, D.V., Thompson, S., Lyons, R.A., The UK Secure eResearch Platform for public health research: a case study. Lancet, 2016 accepted for publication 26th August 2016.
62. [62] H.M. Government, 2014. Care Act http://www.legislation.gov.uk/ukpga/2014/23/contents/enacted.
63. [63] Secure Anonymised Information Linkage databank. http://www.saildatabank.com/.
64. [64] Jones, K.H., Ford, D.V., Jones, C., D'silva, R., Thompson, S., Brooks, C.J., Heaven, M.L., Thayer, D.S., McNerney, C.L., Lyons, R.A., A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: a privacy-protecting remote access system for health-related research and evaluation. J. Biomed. Inform., 2014, 10.1016/j.jbi.2014.01.003.
65. [65] Sethi, N., Laurie, G.T., Delivering proportionate governance in the era of eHealth: making linkage and privacy work together. Med. Law Int. 13:2–3 (2013), 168–204 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952593/.
66. [66] Lea, N.C., Nicholls, J., Dobbs, C., Sethi, N., Cunningham, J., Ainsworth, J., Heaven, M., Peacock, T., Peacock, A., Jones, K.H., Laurie, G., Kalra, D., Data safe havens and trust: towards a common understanding of trusted research platforms for governing secure and ethical health research. JMIR Med. Inform., 4(2), 2016, e22.
67. [67] University of Western Australia, staff profile of CDJ Holman: https://www.socrates.uwa.edu.au/Staff/StaffProfile.aspx?Person=D%27ArcyHolman&tab=publications.
68. [68] Ohm, P., Broken Promises of Privacy: Responding to the Surprising Failure of Anonymization. 2009 http://epic.org/privacy/reidentification/ohm_article.pdf.
69. [69] Information Commissioner's Office, Anonymisation: Managing Data Protection Risk Code of Practice. 2012 http://ico.org.uk/∼/media/documents/library/Data_Protection/Practical_application/anonymisation-codev2.pdf.
70. [70] Frakt, A.B., Bagley, J.D., Protection or harm? Suppressing substance-use data. NEJM 372 (2015), 1879–1881, 10.1056/NEJMp1501362.
71. [71] Allen, J., Holman, C.D.J., Meslin, E.M., Stanley, F., Privacy protectionism and health information: any redress for harms to health?. J. Law Med. 21:2 (2013), 473–485.
72. [72] Council of Canadian Academies, Accessing Health and Health-Related Data in Canada., 2015 http://www.scienceadvice.ca/uploads/eng/assessments%20and%20publications%20and%20news%20releases/health-data/healthdatafullreporten.pdf.
73. [73] National Data Guardian, Review of Data Security, Consent and Opt-Outs. 2016 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/535024/data-security-review.PDF.
74. [74] Laurie, G., Ainsworth, J., Cunningham, J., Dobbs, C., Jones, K.H., Kalra, D., Lea, N., Sethi, N., On moving targets and magic bullets: can the UK lead the way with responsible data linkage for health research?. Int. J. Med. Inf., 84(11), 2015 08/2015.
75. [75] Ploem, M.C., Proposed EU data protection regulation is a threat to medical research. BMJ, 346, 2013, f3534.
76. [76] Stevens, L., The Proposed Data Protection Regulation and Its Potential Impact on Social Sciences Research in the UK. European Data Protection Law Review, EPDL 2/15. 2015 http://www.lexxion.de/images/pdf/edpl_2015_02-005.pdf.
77. [77] European Data in Health Alliance. http://www.datasaveslives.eu/.
78. [78] Wellcome Trust, Vote by European Parliament on Data Protection Welcomed by Research Community. 2015 http://www.wellcome.ac.uk/News/Media-office/Press-releases/2015/WTP060073.htm.
79. [79] European Commission, General Data Protection Regulation. 2015 http://www.statewatch.org/news/2015/dec/eu-council-dp-reg-draft-final-compromise-15039-15.pdf.
80. [80] St. Clair, D., Non-Use of Patient Clinical Data a Greater Risk than Misuse. 2008, Managed Healthcare Executive http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/non-use-patient-clinical-data-greater-risk-misuse?page=full.